AMGEN Could have swept any bad results under the rug..
Instead' They are the one's presenting the data on Tuesday 8am.
Then at 2pm, Cytokinetics has presentations and slides at the Investor Event presented live via webcast-
ALL this for bad or so so results? Highly unlikely....
Obviously Amgen is moving forward with the drug and VERY pleased with results..
Sexy, the company has pretty much stated to not expect anything ground breaking with this study. The COSMIC data in 1st qtr 2015 has more significance for OM. Once we get past this data release then investors can start focusing on the ALS data 1st half 2014 which has far more significance.
Whogo first off cosmic data is being released early 2014 not 2015. Secondly, they never said they didn't expect anything ground breaking. If OME meets dysentery endpoint in atomic study it definitely will be groundbreak